Revenue
2022
2025
IMPACT BIOMEDICAL INC. (IBO)
Price—Loading quote
Net income
2022
2023
2024
2025
Free cash flow
No reported data
Total cash / debt
CashTotal debt
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Revenue | $32,000 | — | — | $50,000 |
| Research & development | $340,000 | $278,000 | $1.7M | $1.2M |
| Operating expenses | $4.3M | $28.8M | $4.0M | — |
| Operating income | −$4.3M | −$28.8M | −$4.0M | −$3.4M |
| EBITDAderived | −$3.1M | −$27.6M | −$2.9M | −$2.3M |
| Net income | −$11.8M | −$24.7M | −$4.3M | −$7.3M |
| Basic EPSper diluted share | -$0.38 | -$2.30 | -$0.07 | -$0.10 |
| Diluted EPSper diluted share | -$0.38 | -$2.30 | -$0.07 | -$0.10 |
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Mar 27, 2026Form 4 | Macko Todd DChief Financial Officer | SellCommon Stock | 43.4K | $0.56 | $24.3K | 155.1K |
| Mar 25, 2026Form 4 | Macko Todd DChief Financial Officer | SellCommon Stock | 1.6K | $0.60 | $960.00 | 198.1K |
| Mar 23, 2026Form 4 | Grady JasonDirector | SellCommon Stock | 50.0K | $0.65 | $32.5K | 250.2K |
| May 27, 2025Form 4 | DSS, INC.TenPercentOwner | SellCommon Stock | 45.4K | $0.54 | $24.5K | 545.0K |
| May 27, 2025Form 4 | DSS, INC.TenPercentOwner | SellCommon Stock | 45.4K | $0.54 | $24.5K | 0 |